|
Mean specific activity of NQO1 in nmol/min/mg of protein (Ratio of the treated/control enzyme specific activities, 95% Confidence Intervals) |
|||||
| Sulforaphane |
BNF |
Curcumin |
DMF |
Control |
|
|
|
|||||
| Liver |
69 (2.5, 2.2–2.9)* |
43 (1.6, 1.5–1.7)* |
34 (1.2, 0.99–1.6) |
32 (1.2, 1.04–1.3)* |
27 |
| Kidney |
41 (2.5, 2.2–2.9)* |
26 (1.6, 1.5–1.7)* |
20 (1.2, 0.99–1.6) |
19 (1.2, 1.04–1.3)* |
16 |
| Prostate |
103 (1.6, 1.4–1.9)* |
80 (1.3, 1.1–1.5)* |
72 (1.2, 0.95–1.4) |
65 (1.04, 0.85–1.3) |
63 |
| Bladder |
26 (4.4, 4.2–4.7)* |
9.0 (1.5,1.2–1.8)* |
10 (1.8, 1.4–2.1)* |
10 (1.8. 1.4–2.2)* |
6.0 |
|
Data are mean values of 8–10 animals in each group * = P < 0.05 based on confidence intervals of the ratio of treated vs. control NQO1 specific activities | |||||
Jones and Brooks BMC Cancer 2006 6:62 doi:10.1186/1471-2407-6-62 |
|||||